Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Acumen Pharmaceuticals, Inc. (ABOS)

0.2235 +0.0097 (+4.54%)
At close: November 6 at 4:00:01 PM EST
0.2202 -0.0033 (-1.48%)
After hours: November 6 at 7:47:11 PM EST
Trade ABOS on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
0
Operating Expense
104,717
123,832
114,017
61,138
45,237
Operating Income
-104,717
-123,832
-114,017
-61,138
-45,237
Net Non Operating Interest Income Expense
60
3,223
10,249
10,210
2,392
Other Income Expense
695
-726
1,439
-1,443
-11
Pretax Income
-103,962
-121,335
-102,329
-52,371
-42,856
Net Income Common Stockholders
-103,962
-121,335
-102,329
-52,371
-42,856
Diluted NI Available to Com Stockholders
-103,962
-121,335
-102,329
-52,371
-42,856
Basic EPS
-1.55
-2.00
-1.71
-1.08
-1.06
Diluted EPS
-1.55
-2.00
-1.71
-1.08
-1.06
Basic Average Shares
67,116.4510
60,561.8360
60,013.2770
48,609.3830
40,601.9360
Diluted Average Shares
67,116.4510
60,561.8360
60,013.2770
48,609.3830
40,601.9360
Total Operating Income as Reported
-104,717
-123,832
-114,017
-61,138
-45,237
Total Expenses
104,717
123,832
114,017
61,138
45,237
Net Income from Continuing & Discontinued Operation
-103,962
-121,335
-102,329
-52,371
-42,856
Normalized Income
-104,742
-120,875
-103,919
-51,011
-42,856
Interest Income
4,309
7,447
14,317
10,791
2,392
Interest Expense
4,249
4,224
4,068
581
0
Net Interest Income
60
3,223
10,249
10,210
2,392
EBIT
-99,713
-117,111
-98,261
-51,790
-42,856
EBITDA
-99,529
-116,927
-98,083
-51,606
-42,687
Reconciled Depreciation
184
184
178
184
169
Net Income from Continuing Operation Net Minority Interest
-103,962
-121,335
-102,329
-52,371
-42,856
Total Unusual Items Excluding Goodwill
780
-460
1,590
-1,360
--
Total Unusual Items
780
-460
1,590
-1,360
--
Normalized EBITDA
-100,309
-116,467
-99,673
-50,246
-42,687
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 7/1/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: